Document is current
Any future updates will be listed below
-
Authors
Yasaka, Masahiro
Suzuki, Michiyasu
Kushimoto, Shigeki
Kiyonaga, Ayako
Mangione, Antoinette
Niwa, Yuki
Terasaka, Naoki https://orcid.org/0009-0009-2767-5060
-
Funding
Funding for this research was provided by:
CSL Behring
- License Information
-
More Information
Article History
Received: 21 December 2023
Accepted: 18 January 2024
First Online: 6 February 2024
Declarations
:
: Ayako Kiyonaga, Antoinette Mangione, Yuki Niwa, Naoki Terasaka are full-time employees of CSL Behring. Masahiro Yasaka has received lecture, advisory, and travel fees from Bristol-Myers Squibb, Nippon Boehringer Ingelheim, Bayer, Daiichi Sankyo, and CSL Behring, as well as scholarship funds or nonrestricted grants from Nippon Boehringer Ingelheim. Michiyasu Suzuki has received lecture fees from Nippon Boehringer Ingelheim and CSL Behring. Shigeki Kushimoto has received lecture fee from CSL Behring.
: The study was conducted according to the Declaration of Helsinki (1964 and its later amendments). The study was also complied in accordance with Japanese Good Postmarketing Study Practice (GPSP) regulations. The protocol was reviewed and approved by the Japanese regulatory authority, PMDA, and by the ethics committees; written informed consent was obtained from all patients.
